Search Results - "Yang, Qiaolu"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study by Lin, Yilong, Zhang, Yue, Wang, Songsong, Cao, Lin, Zhao, Ruidan, Ma, Xilai, Yang, Qiaolu, Zhang, Liyi, Yang, Qingmo

    Published in Frontiers in pharmacology (06-08-2024)
    “…The relationship between sodium-glucose cotransporter 2 (SGLT2) inhibitors and prostate cancer is still unknown. Although these inhibitors can influence tumor…”
    Get full text
    Journal Article
  2. 2

    Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo by Meng, Minjun, Yang, Qiaolu, Ouyang, Zhong, Yang, Qingmo, Wu, Xinyi, Huang, Yufan, Su, Yonghui, Chen, Shuanglong, Chen, Wenlin

    Published in Acta pharmaceutica (Zagreb, Croatia) (01-03-2023)
    “…Breast cancer is one of the most common malignant tumors in women and it is the most frequently diagnosed cancer in the world. Ampelopsin (AMP) is a purified…”
    Get full text
    Journal Article
  3. 3

    Effect of Stereotactic Body Radiation Therapy Combined with Thermoplastic Fixation on Set-Up Errors in Breast Cancer Patients Undergoing Radiotherapy by Zhu, Luchao, Liu, Jun, Li, Yimin, Yang, Qiaolu, Wu, Qiong, Lin, Qing, Chen, Sijia

    “…Objective. To investigate the effect of stereotactic radiotherapy (SBRT) combined with thermoplastic fixation on set-up error in breast cancer (BC) patients…”
    Get full text
    Journal Article
  4. 4

    Evaluation of chidamide and PFI-1 as a combination therapy for triple-negative breast cancer by Lin, Nong, Yang, Qiaolu, Xu, Tong, Shi, Lianguo

    “…Purpose: To evaluate the in vitro and in vivo effects of the combination therapy of histone deacetylases (HDAsC) inhibitor, chidamide, and…”
    Get full text
    Journal Article